BDSI was founded by Frank O'Donnell who has a 30 year history of public company bankruptcies, shareholder lawsuits, and SEC investigations into companies he was the Chairman of.
Insiders are Selling (Frank O'Donnell & Broadfin Capital).
BDSI pays doctors with questionable history and engages in other questionable business practices like co-pay cards for free opioids.
BDSI is an unprofitable opioid company with high cost 12.5% debt.
10-K disclosure shows that generic Belbuca (BDSI's only growing drug) could be coming sooner than management has indicated.
We are short BioDelivery Sciences International (BDSI), a money losing opioid manufacturer that was co-founded by Dr. Frank O’Donnell, Jonnie Williams’ long-time business partner. Dr. O'Donnell and Jonnie Williams are two individuals whose